INTERPACE BIOSCIENCES, INC. (IDXG)

Import this data to Google Sheets with:

=jivedata("IDXG","financials")

Full statements spill as a table. For one cell: =jivedata("IDXG","Revenue") or =jivedata("IDXG","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

INTERPACE BIOSCIENCES, INC.

IDXG • CIK 0001054102

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$40,214	$46,926	$38,728	$36,144
Cost of Revenue	$16,310	$17,001	$14,598	$13,103
Gross Profit	$23,904	$29,925	$24,130	$23,041
Operating Income (Loss)	$2,804	$8,108	$4,084	$4,167
Accretion Expense	—	$34	$34	$34
Interest Expense, Long-term Debt	$896	$625	$168	$168
Other Operating Income (Expense), Net	—	—	$-142	$-128
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$1,129	$6,950	$3,774	$3,998
Income Tax Expense (Benefit)	$17	$4	$-21,210	$-20,862
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$1,112	$6,946	$24,984	$24,860
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$-310	$-244	$-409	$-413
Net Income (Loss) Attributable to Parent	$802	$6,702	$24,575	$24,447
Preferred Stock Dividends, Income Statement Impact	—	$464	$464	$464
Net Income (Loss) Available to Common Stockholders, Basic	—	$6,238	$24,575	$24,575
Selling and Marketing Expense	$10,233	$11,655	$9,924	$8,585
Research and Development Expense	$636	$676	$642	$593
General and Administrative Expense	$9,363	$9,486	$9,480	$9,696
Operating Expenses	$21,100	$21,817	$20,046	$18,874
Weighted Average Number of Shares Outstanding, Basic	4,317,000	4,387,000	4,424,000	24,794,000
Weighted Average Number of Shares Outstanding, Diluted	4,364,000	15,734,000	27,695,000	27,243,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	693,000	446,000	396,000	352,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$3,498	$1,461	$2,505	$2,688
Accounts Receivable, after Allowance for Credit Loss, Current	$4,983	$8,544	$5,649	$6,311
Property, Plant and Equipment, Net	$790	$1,361	$1,423	$1,621
Other Assets, Current	$1,841	$1,768	$1,746	$1,969
Operating Lease, Right-of-Use Asset	$1,864	$1,613	$1,217	$1,001
Assets, Current	$10,322	$11,773	$9,900	$10,968
Deferred Income Tax Assets, Net	—	—	$21,254	$20,915
Other Assets, Noncurrent	$45	$45	$44	$44
Assets	$13,021	$14,792	$33,838	$34,549
Operating Lease, Liability, Noncurrent	$1,472	$1,183	$752	$516
Other Liabilities, Noncurrent	$4,968	$5,211	$5,620	$5,838
Liabilities	$28,157	$17,009	$11,475	$11,305
Accounts Payable, Current	$1,544	$1,659	$983	$1,555
Employee-related Liabilities, Current	$1,969	$2,207	$1,886	$952
Other Accrued Liabilities, Current	$8,201	$1,799	$1,574	$1,784
Notes Payable, Current	$5,100	$4,290	$4,290	$977
Disposal Group, Including Discontinued Operation, Liabilities, Current	$660	$660	$660	$660
Liabilities, Current	$17,474	$10,615	$5,103	$4,951
Common Stock, Value, Issued	$405	$406	$407	$640
Additional Paid in Capital, Common Stock	$188,146	$234,811	$234,833	$234,608
Retained Earnings (Accumulated Deficit)	$-248,215	$-235,380	$-210,805	$-209,926
Treasury Stock, Value	$2,008	$2,054	$2,072	$2,078
Stockholders' Equity Attributable to Parent	$-61,672	$-2,217	$22,363	$23,244
Preferred Stock, Shares Authorized	—	5,000,000	5,000,000	5,000,000
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	4,447,489	4,539,663	4,569,333	27,844,994
Common Stock, Shares, Outstanding	4,351,445	4,409,323	4,428,539	27,700,904
Treasury Stock, Common, Shares	96,044	130,340	140,794	140,794

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$802	$6,702	$24,575	$24,447
Net Cash Provided by (Used in) Operating Activities	$3,789	$4,646	$5,831	$4,457
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-1,330	$-2,037	$1,044	$2,186
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$3,498	$1,461	$2,505	$3,956
Depreciation, Depletion and Amortization	$1,026	$300	$425	$474
Payments to Acquire Property, Plant, and Equipment	$470	$876	$356	$353
Accretion Expense	—	$34	$34	$34
Net Cash Provided by (Used in) Investing Activities	$-87	$-876	$-356	$-353
Asset Impairment Charges	—	—	$198	$198
Amortization of Debt Issuance Costs	$42	$42	$58	$58
Share-based Payment Arrangement, Noncash Expense	$630	$291	$35	$19
Operating Lease, Right-of-Use Asset, Amortization Expense	$575	$448	$396	$419
Deferred Income Taxes and Tax Credits	—	—	$-21,254	$-21,254
Repayments of Notes Payable	—	$5,600	$4,400	$4,400
Payments of Stock Issuance Costs	—	$161	$13	$13
Payments for Repurchase of Other Equity	$32	$46	$18	$18
Net Cash Provided by (Used in) Financing Activities	$-5,032	$-5,807	$-4,431	$-4,431
Increase (Decrease) in Accounts Receivable	$-49	$3,466	$-2,895	$-920
Increase (Decrease) in Other Current Assets	$89	$-73	$234	$447
Increase (Decrease) in Accounts Payable	$489	$120	$-807	$-71
Increase (Decrease) in Accrued Liabilities	$-936	$-404	$-273	$-273
IncreaseDecreaseInOperatingLeaseLiability	$-376	$-480	$-382	$-460
Increase (Decrease) in Other Noncurrent Liabilities	$267	$243	$409	$413

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IDXG","financials")

Full statements spill as a table. For one cell: =jivedata("IDXG","Revenue") or =jivedata("IDXG","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.